| Patents for G01N 33 - Investigating or analysing materials by specific methods not covered by groups (393,632) |
|---|
| 03/21/2002 | WO2002022684A2 Transporters and ion channels |
| 03/21/2002 | WO2002022682A1 Interferon-alpha induced gene |
| 03/21/2002 | WO2002022678A2 Isolated human transporter proteins, nucleic acid molecules encoding human transporter proteins, and uses thereof |
| 03/21/2002 | WO2002022664A2 Antigenic proteins of shrimp white spot syndrome virus and uses thereof |
| 03/21/2002 | WO2002022649A2 Screening methods to identify g-proteins and other compounds which modulate phosphodiesterase (pde) activity |
| 03/21/2002 | WO2002022648A2 Compositions and methods for inducing specific cytolytic t cell responses |
| 03/21/2002 | WO2002022629A1 Anti-stilbene antibodies |
| 03/21/2002 | WO2002022573A2 Methods and compositions relating to hydrogen peroxide and superoxide production by antibodies |
| 03/21/2002 | WO2002022264A2 Method and apparatus for gradient generation |
| 03/21/2002 | WO2002022165A1 Non-genetic based protein disease markers |
| 03/21/2002 | WO2002022161A2 The diagnosis, prevention, and/or treatment of atherosclerosis and underlying and/or related diseases |
| 03/21/2002 | WO2002022160A2 The diagnosis, prevention, amelioration and/or treatment of disturbed immune function induced by disturbed lipid metabolism |
| 03/21/2002 | WO2002022076A2 Means and methods for monitoring protease inhibitor antiretroviral therapy and guiding therapeutic decisions in the treatment of hiv/aids |
| 03/21/2002 | WO2002022075A2 Odors discrimination based on spectral signatures |
| 03/21/2002 | WO2002022007A2 Chemical sensing instrument and related method of use |
| 03/21/2002 | WO2002021996A2 Methods of diagnosis of colorectal cancer, compositions and methods of screening for colorectal cancer modulators |
| 03/21/2002 | WO2002000927A8 Diagnosis of diseases associated with development by means of assessing their methylation status |
| 03/21/2002 | WO2001096867A3 Method for identifying insulin mimics or antagonists |
| 03/21/2002 | WO2001096388A8 Compositions and methods for the therapy and diagnosis of colon cancer |
| 03/21/2002 | WO2001087567B1 Method and device for the dry separation of unsorted garbage that contains packaging waste |
| 03/21/2002 | WO2001087039A3 Treatment of neoplasia / transformation using pituitary tumor transforming gene 2 |
| 03/21/2002 | WO2001086266A3 Pd/v2 05 device for colorimetric h2 detection |
| 03/21/2002 | WO2001084145A3 Device for monitoring analytes at sub-micromolar concentrations |
| 03/21/2002 | WO2001081546A3 CeSERT GENES, PROTEINS, AND MODULATORY COMPOUNDS |
| 03/21/2002 | WO2001079523A3 Method and system for microorganism identification by mass spectrometry-based proteome database searching |
| 03/21/2002 | WO2001079484A3 Method for detecting iodized thyroglobulin in human serum after thyroid ablation |
| 03/21/2002 | WO2001077376A8 Diagnosis of diseases associated with metastasis |
| 03/21/2002 | WO2001077303A3 Human ovarian mesothelial cells and methods of isolation and uses thereof |
| 03/21/2002 | WO2001077164A8 Diagnosis of diseases associated with apoptosis by means of assessing the methylation status of genes associated with apoptosis |
| 03/21/2002 | WO2001074158A3 Systems and methods for collecting leukocyte-reduced blood components, including plasma that is free or virtually free of cellular blood species |
| 03/21/2002 | WO2001073124A3 Rapid response glucose sensor |
| 03/21/2002 | WO2001072841A3 Isolated human g-protein coupled receptors that are members of the aminergic subfamily, nucleic acid molecules encoding human gpcr proteins, and uses thereof |
| 03/21/2002 | WO2001072840A3 Isolated human g-protein coupled receptors of the mas proto-oncogene subfamily, nucleic acid molecules encoding human gpcr proteins, and uses thereof |
| 03/21/2002 | WO2001069302A3 Fiber optic scanner |
| 03/21/2002 | WO2001068861A3 THREE-DIMENSIONAL MODEL OF A Fc REGION OF AN IgE ANTIBODY AND USES THEREOF |
| 03/21/2002 | WO2001068664A3 Mass labels |
| 03/21/2002 | WO2001068123A3 Monocyte chemoattractant activity of galectin-3 |
| 03/21/2002 | WO2001067108A3 Diagnostic assay for transmissible spongiform encephalopathies |
| 03/21/2002 | WO2001065509A3 Cellular telephone interactive wagering system |
| 03/21/2002 | WO2001064344A3 Microfabricated devices for the storage and selective exposure of chemicals and devices |
| 03/21/2002 | WO2001063101A3 Method for determining motor oil wear |
| 03/21/2002 | WO2001062942A3 MATERIALS AND METHODS INVOLVING HYBRID VASCULAR ENDOTHELIAL GROWTH FACTOR DNAs AND PROTEINS AND SCREENING METHODS FOR MODULATORS |
| 03/21/2002 | WO2001062725A3 Methods and compositions for inhibiting angiogenesis |
| 03/21/2002 | WO2001061352A8 Production of a protein biosensor with a defined binding matrix |
| 03/21/2002 | WO2001061329A3 Method for isolating a proportion of a fluid mixture |
| 03/21/2002 | WO2001060991A3 Human kinases |
| 03/21/2002 | WO2001057534A3 Compositions and methods for reducing autoimmunity |
| 03/21/2002 | WO2001057517A3 Method for detecting or quantitatively determining additives in asphalt |
| 03/21/2002 | WO2001050130A3 Screening methods for compounds useful in the treatment of polycystic kidney disease |
| 03/21/2002 | WO2001040465A3 Compositions and methods for the treatment of immune related diseases |
| 03/21/2002 | WO2001037191A3 Method for manipulating protein or dna sequence data (in order to generate complementary peptide ligands) |
| 03/21/2002 | WO2001020039A3 Method of sequencing a nucleic acid |
| 03/21/2002 | WO2001016857A3 System and method for genomic and proteomic agricultural disease assessment via expression profile comparison |
| 03/21/2002 | WO2001012855A3 Binary encoded sequence tags |
| 03/21/2002 | WO2000073412A3 Apparatus and method for analyzing a fluid sample |
| 03/21/2002 | WO2000063444A3 Method for detecting hepatitis c virus with hybridomas |
| 03/21/2002 | WO2000052208A3 Customized oligonucleotide microchips that convert multiple genetic information to simple patterns |
| 03/21/2002 | US20020035459 Pharmacokinetic-based drug design tool and method |
| 03/21/2002 | US20020035436 Fluid contaminant sensor |
| 03/21/2002 | US20020035433 Method for the analysis and evaluation of at least three-dimensional specimen data |
| 03/21/2002 | US20020035325 Method for detecting lymphoid tissue in tumor progression |
| 03/21/2002 | US20020035303 Solvent extraction |
| 03/21/2002 | US20020035246 SMAD-interacting polypeptides and their use |
| 03/21/2002 | US20020035240 Novel mammalian cell cycle protein |
| 03/21/2002 | US20020035084 Protecting the agent (such as chemotherapeutic agent) within a lipid structure, causing lipase activity to be constituted in response to predetermined conditions, and exposing the lipid structure to release the agent |
| 03/21/2002 | US20020035061 Compositions and methods for treating infections using cationic peptides alone or in combination with antibiotics |
| 03/21/2002 | US20020035060 Pharmaceutical compositions, methods, and kits for treatment and diagnosis of lung cancer |
| 03/21/2002 | US20020034828 Bound to analyte or its ligand by biotin-avidin or biotin-streptavidin bridge; reacts with analyte or its ligand bound to solid phase; signal solution added; emitted light proportional to concentration of analyte or its ligand |
| 03/21/2002 | US20020034827 Separation of preferential particles from sample; provide probes, incubate with sample, separate probes from sample, classify extraction probes |
| 03/21/2002 | US20020034826 Optical-chemical Sensor |
| 03/21/2002 | US20020034824 Apparatus for use in the analysis of erythrocytes, leukocyes and hemoglobin |
| 03/21/2002 | US20020034806 Isolated human phospholipase proteins, nucleic acid molecules encoding human phospholipase proteins, and uses thereof |
| 03/21/2002 | US20020034803 Isolated human kinase proteins, nucleic acid molecules encoding human kinase proteins, and uses thereof |
| 03/21/2002 | US20020034802 Crystals of the alpha 1 beta 1 integrin I-domain and their use |
| 03/21/2002 | US20020034787 Nucleotide sequences coding polypeptides for use in treatment of wounds, burns, ulcers, nervous system disorders and tumors |
| 03/21/2002 | US20020034786 Nucleotide sequences coding G protein coupled receptor; for use in the diagnosis and treatment of defects in signal transduction |
| 03/21/2002 | US20020034779 Novel argS |
| 03/21/2002 | US20020034778 Peptide; for use in drug screening; for use as a diagnostic tool; for use in the treatment of nervous system disorders |
| 03/21/2002 | US20020034777 Modulator of use in the diagnosis, prevention and treatment of inflammation, cancer and nervous system disorders; hypotensive agent |
| 03/21/2002 | US20020034775 Diagnosis of preferential enzymatic defect in humans; obtain sample of body fluid, monitor enzymatic activity, compare to control, adjustment in enzyme activity indicates defect |
| 03/21/2002 | US20020034774 Treatment or prophylaxis of diseases caused by pilus-forming bacteria |
| 03/21/2002 | US20020034773 Diagnosis cell proliferation defects; obtain sample, detect preferential protein, measure concentration, compare to control, an increase in preferential protein concentration indicates tumors |
| 03/21/2002 | US20020034772 Methods and compositions that affect melanogenesis |
| 03/21/2002 | US20020034771 Screening for preferential immunoglobulin; obtain human immunoglobulin receptor segment, incubate with antigen, detect complex formation |
| 03/21/2002 | US20020034769 Novel glycolipid complexes and their uses |
| 03/21/2002 | US20020034766 Molecular modification assays |
| 03/21/2002 | US20020034764 Diarylsulfonylurea binding proteins |
| 03/21/2002 | US20020034763 Immunoglobulin that binds to preferential cell surface protein; for use in detection of preferential microorganisms |
| 03/21/2002 | US20020034762 Monitorng preferential particles in sample; provide opaque glass support, incubate with sample, illuminate surface with light, monitor fluorescent emission, emission indicates presence of preferential particle in sample |
| 03/21/2002 | US20020034759 Metallic solid supports modified with nucleic acids |
| 03/21/2002 | US20020034758 Novel human genes and gene expressions products: II |
| 03/21/2002 | US20020034756 Method of detection by enhancement of silver staining |
| 03/21/2002 | US20020034755 Polypeptides having a functional domain of interest and methods of identifying and using same |
| 03/21/2002 | US20020034753 Novel assay for nucleic acid analysis |
| 03/21/2002 | US20020034747 Using encoded bead conjugate comprising microsphere semiconductor nanocrystal having fluorescence characteristics and polynucleotide having proximal end and distal end wherein polynucleotide is linked to microsphere at proximal end |
| 03/21/2002 | US20020034746 Computer program product for quantitative analysis of a nucleic acid amplification reaction |
| 03/21/2002 | US20020034745 Device for determining transition point in cycled propagation reaction; for use as diagnostic tools in nucleotide sequences analysis |
| 03/21/2002 | US20020034744 Providing electrode in electrical communication with solution, providing sacrificial reagent, transferring charge from sacrificial reagant to analyte, from analyte to electrode, generating electrical signal, amplifying and measuring |
| 03/21/2002 | US20020034743 Nucleotide sequences coding protein for use in the detection, diagnosis, prevention and treatment of human cancers |
| 03/21/2002 | US20020034735 Applying mixed solution comprising adenovirus and undesired type of biomolecule to anion exchange chromatography resin containing binding moiety such as dimethylaminopropyl such that adenovirus binds to resin, eluting |